questionsmedicales.fr
Lipides
Lipides membranaires
Stérols
Cholestérol
Oxystérols
Oxystérols : Questions médicales fréquentes
Termes MeSH sélectionnés :
Early Detection of Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Oxystérols : Questions médicales les plus fréquentes",
"headline": "Oxystérols : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Oxystérols : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-17",
"dateModified": "2025-04-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Oxystérols"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cholestérol",
"url": "https://questionsmedicales.fr/mesh/D002784",
"about": {
"@type": "MedicalCondition",
"name": "Cholestérol",
"code": {
"@type": "MedicalCode",
"code": "D002784",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.938.208"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hydroxycholestérols",
"alternateName": "Hydroxycholesterols",
"url": "https://questionsmedicales.fr/mesh/D006888",
"about": {
"@type": "MedicalCondition",
"name": "Hydroxycholestérols",
"code": {
"@type": "MedicalCode",
"code": "D006888",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.938.208.825.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cétocholestérols",
"alternateName": "Ketocholesterols",
"url": "https://questionsmedicales.fr/mesh/D007653",
"about": {
"@type": "MedicalCondition",
"name": "Cétocholestérols",
"code": {
"@type": "MedicalCode",
"code": "D007653",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.570.938.208.825.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Oxystérols",
"alternateName": "Oxysterols",
"code": {
"@type": "MedicalCode",
"code": "D000072376",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yuqin Wang",
"url": "https://questionsmedicales.fr/author/Yuqin%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Swansea University Medical School, ILS1 Building, Singleton Park, Swansea SA2 8PP, UK. y.wang@swansea.ac.uk."
}
},
{
"@type": "Person",
"name": "William J Griffiths",
"url": "https://questionsmedicales.fr/author/William%20J%20Griffiths",
"affiliation": {
"@type": "Organization",
"name": "Swansea University Medical School, ILS1 Building, Singleton Park, Swansea SA2 8PP, UK. w.j.griffiths@swansea.ac.uk."
}
},
{
"@type": "Person",
"name": "Caroline Pot",
"url": "https://questionsmedicales.fr/author/Caroline%20Pot",
"affiliation": {
"@type": "Organization",
"name": "Laboratories of Neuroimmunology, Neuroscience Research Center and Division of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital and Lausanne University, Chemin des Boveresses 155, 1066 Epalinges, Switzerland. Caroline.Pot-Kreis@chuv.ch."
}
},
{
"@type": "Person",
"name": "Gérard Lizard",
"url": "https://questionsmedicales.fr/author/G%C3%A9rard%20Lizard",
"affiliation": {
"@type": "Organization",
"name": "Team \"Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism\" EA 7270/Inserm, University Bourgogne Franche-Comté, Dijon, France."
}
},
{
"@type": "Person",
"name": "Eylan Yutuc",
"url": "https://questionsmedicales.fr/author/Eylan%20Yutuc",
"affiliation": {
"@type": "Organization",
"name": "Swansea University Medical School, ILS1 Building, Singleton Park, Swansea SA2 8PP, UK. eylan.yutuc@swansea.ac.uk."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Lobar or sublobar resection for early-stage second primary lung cancer ≤ 3 cm in size: a SEER population-based study.",
"datePublished": "2023-09-19",
"url": "https://questionsmedicales.fr/article/37725243",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00432-023-05396-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "An optimal dose-fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early-stage non-small lung cancer.",
"datePublished": "2023-09-10",
"url": "https://questionsmedicales.fr/article/37691151",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1759-7714.15071"
}
},
{
"@type": "ScholarlyArticle",
"name": "Survival Outcomes and Efficacy of Platinum in Early Breast Cancer Patients with Germline BRCA1 or BRCA2 Mutation: A Multicenter Retrospective Cohort Study.",
"datePublished": "2023-09-04",
"url": "https://questionsmedicales.fr/article/37692097",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2147/BCTT.S423330"
}
},
{
"@type": "ScholarlyArticle",
"name": "The International Association for the Study of Lung Cancer Early Lung Imaging Confederation Open-Source Deep Learning and Quantitative Measurement Initiative.",
"datePublished": "2023-08-16",
"url": "https://questionsmedicales.fr/article/37595684",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jtho.2023.08.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of distance to tertiary centre on enrolment of paediatric patients with relapsed or refractory cancer on early phase clinical trials in British Columbia.",
"datePublished": "2023-08-16",
"url": "https://questionsmedicales.fr/article/39045479",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/pch/pxad044"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Lipides",
"item": "https://questionsmedicales.fr/mesh/D008055"
},
{
"@type": "ListItem",
"position": 3,
"name": "Lipides membranaires",
"item": "https://questionsmedicales.fr/mesh/D008563"
},
{
"@type": "ListItem",
"position": 4,
"name": "Stérols",
"item": "https://questionsmedicales.fr/mesh/D013261"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cholestérol",
"item": "https://questionsmedicales.fr/mesh/D002784"
},
{
"@type": "ListItem",
"position": 6,
"name": "Oxystérols",
"item": "https://questionsmedicales.fr/mesh/D000072376"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Oxystérols - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Oxystérols",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Oxystérols",
"description": "Comment diagnostiquer une dysfonction liée aux oxystérols ?\nQuels tests sont utilisés pour mesurer les oxystérols ?\nLes symptômes peuvent-ils indiquer un excès d'oxystérols ?\nY a-t-il des biomarqueurs pour les oxystérols ?\nComment les oxystérols sont-ils liés aux maladies cardiovasculaires ?",
"url": "https://questionsmedicales.fr/mesh/D000072376?mesh_terms=Early+Detection+of+Cancer&page=997#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Oxystérols",
"description": "Quels sont les symptômes d'une accumulation d'oxystérols ?\nLes oxystérols peuvent-ils affecter le système nerveux ?\nY a-t-il des signes cutanés liés aux oxystérols ?\nComment les oxystérols influencent-ils le métabolisme ?\nPeut-on ressentir des douleurs musculaires avec des oxystérols élevés ?",
"url": "https://questionsmedicales.fr/mesh/D000072376?mesh_terms=Early+Detection+of+Cancer&page=997#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Oxystérols",
"description": "Comment prévenir les troubles liés aux oxystérols ?\nLe contrôle du poids aide-t-il à prévenir les problèmes d'oxystérols ?\nLes examens réguliers sont-ils importants pour les oxystérols ?\nL'exercice physique influence-t-il les niveaux d'oxystérols ?\nLes habitudes alimentaires peuvent-elles prévenir les troubles d'oxystérols ?",
"url": "https://questionsmedicales.fr/mesh/D000072376?mesh_terms=Early+Detection+of+Cancer&page=997#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Oxystérols",
"description": "Quels traitements existent pour les troubles liés aux oxystérols ?\nLes statines sont-elles efficaces contre les oxystérols ?\nY a-t-il des thérapies ciblées pour les oxystérols ?\nComment la diététique aide-t-elle à gérer les oxystérols ?\nLes suppléments peuvent-ils aider à réguler les oxystérols ?",
"url": "https://questionsmedicales.fr/mesh/D000072376?mesh_terms=Early+Detection+of+Cancer&page=997#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Oxystérols",
"description": "Quelles complications peuvent survenir avec des oxystérols élevés ?\nLes oxystérols sont-ils liés à des maladies hépatiques ?\nPeut-on développer un diabète avec des oxystérols anormaux ?\nLes troubles cognitifs sont-ils liés aux oxystérols ?\nLes oxystérols peuvent-ils affecter la santé osseuse ?",
"url": "https://questionsmedicales.fr/mesh/D000072376?mesh_terms=Early+Detection+of+Cancer&page=997#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Oxystérols",
"description": "Quels sont les facteurs de risque pour les troubles d'oxystérols ?\nL'hérédité joue-t-elle un rôle dans les troubles d'oxystérols ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe tabagisme influence-t-il les niveaux d'oxystérols ?\nLe stress peut-il affecter les niveaux d'oxystérols ?",
"url": "https://questionsmedicales.fr/mesh/D000072376?mesh_terms=Early+Detection+of+Cancer&page=997#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction liée aux oxystérols ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins mesurant les niveaux d'oxystérols."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer les oxystérols ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang spécifiques, comme la chromatographie, sont utilisées."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils indiquer un excès d'oxystérols ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fatigue ou des troubles neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs pour les oxystérols ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains oxystérols peuvent servir de biomarqueurs dans des pathologies spécifiques."
}
},
{
"@type": "Question",
"name": "Comment les oxystérols sont-ils liés aux maladies cardiovasculaires ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés d'oxystérols sont associés à un risque accru de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une accumulation d'oxystérols ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleurs abdominales et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les oxystérols peuvent-ils affecter le système nerveux ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux peuvent entraîner des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés liés aux oxystérols ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées ou des anomalies peuvent survenir en cas d'accumulation."
}
},
{
"@type": "Question",
"name": "Comment les oxystérols influencent-ils le métabolisme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils régulent le métabolisme lipidique, affectant le stockage et l'utilisation des graisses."
}
},
{
"@type": "Question",
"name": "Peut-on ressentir des douleurs musculaires avec des oxystérols élevés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs musculaires peuvent être un symptôme d'une dysfonction lipidique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux oxystérols ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine et un mode de vie actif sont essentiels pour la prévention."
}
},
{
"@type": "Question",
"name": "Le contrôle du poids aide-t-il à prévenir les problèmes d'oxystérols ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un poids santé peut réduire le risque de troubles liés aux oxystérols."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants pour les oxystérols ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans de santé réguliers aident à détecter les anomalies précocement."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il les niveaux d'oxystérols ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut aider à réguler les niveaux d'oxystérols dans le sang."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires peuvent-elles prévenir les troubles d'oxystérols ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en fibres et faible en graisses saturées est bénéfique."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les troubles liés aux oxystérols ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des modifications diététiques et des médicaments hypolipémiants."
}
},
{
"@type": "Question",
"name": "Les statines sont-elles efficaces contre les oxystérols ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les statines peuvent aider à réduire les niveaux d'oxystérols dans le sang."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies ciblées pour les oxystérols ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies ciblées sont en développement pour traiter les dysfonctionnements liés."
}
},
{
"@type": "Question",
"name": "Comment la diététique aide-t-elle à gérer les oxystérols ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut réduire les niveaux d'oxystérols et améliorer la santé."
}
},
{
"@type": "Question",
"name": "Les suppléments peuvent-ils aider à réguler les oxystérols ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les oméga-3, peuvent aider à équilibrer les lipides."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des oxystérols élevés ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies cardiovasculaires et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les oxystérols sont-ils liés à des maladies hépatiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés peuvent contribuer à des maladies du foie et à la stéatose."
}
},
{
"@type": "Question",
"name": "Peut-on développer un diabète avec des oxystérols anormaux ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux d'oxystérols anormaux peuvent augmenter le risque de diabète."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils liés aux oxystérols ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés peuvent être associés à des troubles cognitifs et à la démence."
}
},
{
"@type": "Question",
"name": "Les oxystérols peuvent-ils affecter la santé osseuse ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres peuvent influencer la santé osseuse et le risque de fractures."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles d'oxystérols ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, une alimentation riche en graisses et le diabète."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans les troubles d'oxystérols ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de dyslipidémies augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire contribue à des niveaux élevés d'oxystérols."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les niveaux d'oxystérols ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut aggraver les dysfonctionnements lipidiques et les niveaux d'oxystérols."
}
},
{
"@type": "Question",
"name": "Le stress peut-il affecter les niveaux d'oxystérols ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber le métabolisme lipidique et augmenter les oxystérols."
}
}
]
}
]
}
Surgical strategy for second primary lung cancer (SPLC) may be more conservative due to influence of first primary lung cancer (FPLC). The optimal surgical method for SPLC warrants discussion. We aime...
A retrospective study was conducted using data from the Surveillance, Epidemiology and End Results database between 2004 and 2018, and data of patients with early-stage SPLC who underwent secondary su...
A total of 714 patients who met the study entry criteria were enrolled, including 476 patients in the sublobar resection group (66.67%) and 238 patients in the lobar resection group (33.33%). There wa...
The OS of sublobar resection was not significantly different from that of lobar resection for early-stage SPLC. For SPLC with a 2-3 cm tumor size, lobar resection is more advantageous than sublobar re...
Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), is commonly used in inoperable patients with early-stage non-small lung cancer (NSCLC). This treatment h...
The study aimed to compare the survival outcomes and efficacy of platinum in early breast cancer patients with BRCA1 and BRCA2 mutations....
Patients diagnosed with stage I-III breast cancer and carrying germline pathogenic/likely pathogenic BRCA mutations in three medical institutions in China from April 2016 to January 2021 were retrospe...
One hundred and sixty-nine patients with BRCA mutations were enrolled, including BRCA1 mutation (53.3%, n = 90) and BRCA2 mutation (46.7%, n = 79). The median age was 39 years, and most patients (68.1...
Similar survival outcomes were observed in early breast cancer patients with BRCA1 and BRCA2 mutation, though they had different biological characteristics. Patients with BRCA1 mutations are more bene...
With global adoption of computed tomography (CT) lung cancer screening, there is increasing interest to use artificial intelligence (AI) deep learning methods to improve the clinical management proces...
In this second phase of the initiative, metadata and screening CT scans from two time points were collected from 100 screening participants in seven countries. An automated deep learning AI lung segme...
A total of 1394 CTs were collected from 697 participants. The LAV950 quantitative emphysema metric was found to be potentially useful in distinguishing lung cancer from benign cases using a combined s...
These initial experiments revealed that ELIC can support deep learning AI and quantitative imaging analyses on diverse and globally distributed cloud-based data sets....
Access to early phase trials for children with relapsed, refractory or progressive (RRPD) cancer is limited in Canada. Patients and families face barriers to access trials, which are poorly understood...
Oncology patients ≤18 years at diagnosis who later had RRPD were identified retrospectively via registry at the only quaternary paediatric oncology centre in British Columbia (BC). We determined if di...
Between January 2015 and July 2021, 266 patients experienced 396 RRPD events. Seventy-five patients (28.2%) were eligible for an early phase trial at least once. At first eligible event, 61 patients (...
Children in BC with cancer and RRPD have limited access to early phase trials. Distance was not predictive of enrolment, suggesting that families travel to access therapy....
Ovarian cancer (OV) is the most lethal gynecological malignancy and requires improved early detection methods and more effective intervention to achieve a better prognosis. The lack of sensitive and n...
The aim of this work was to prospectively evaluate the toxicity and cosmetic outcomes of 5-fraction, stereotactic, accelerated partial breast irradiation (APBI)....
This prospective observational cohort study enrolled women who underwent APBI for invasive carcinoma or carcinoma in situ of the breast. APBI was delivered using a CyberKnife M6 robotic radiosurgery s...
In total, 204 patients (APBI, n = 103; WBI, n = 101) were enrolled. Regarding patient-reported outcomes, the APBI group reported significantly less skin dryness (6.9% vs 18.3%; P = .015), radiation sk...
Stereotactic APBI was associated with less fibrosis in the uninvolved breast quadrants than WBI. Patients showed minimal toxicity and no detrimental effects on cosmesis after APBI....
Synchronous multiple primary colorectal cancer (SMPCC) involves the simultaneous occurrence of 2 or more independent primary malignant tumors in the colon or rectum. Although SMPCC is rare, it results...
The clinical factors and survival outcomes of SMPCC patients registered on the Surveillance, Epidemiology, and End Results (SEER) database between 2000 and 2017 were extracted. The patients were divid...
A total of 4386 SMPCC patients were enrolled in the study and randomly assigned to the training (n = 3070) and validation (n = 1316) cohorts. The multivariate logistic analysis identified age, chemoth...
Our nomogram can provide a simple and accurate tool for clinicians to predict the risk of early death in SMPCC patients undergoing surgery and could be used to optimize the treatment according to the ...
[This corrects the article DOI: 10.7150/thno.34755.]....
Early-onset colorectal cancer (CRC) has different clinical and pathological characteristics compared with late-onset CRC. Mortality rate as a postoperative outcome is a patient's postoperative outcome...
The authors performed a case-control study on 170 subjects with CRC from November 2021 to November 2022 in a Tertiary Hospital in Bandung. Data were extracted from electronic medical records CRC Regis...
Anaemia and tumour location variables were significantly different in the early-onset group compared with the late-onset group (...
There is no statistically significant correlation between the clinicopathological features of CRC in both onset and mortality rates in this study....